Home Transcutaneous Electrical Acustimulation (TEA)
Status:
Not yet recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy of two active treatments with TEA and a chemical
neuromodulator (escitalopram aka Lexapro) versus a sham comparator or control group on
abdominal pain.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Michigan
Collaborators:
National Center for Complementary and Integrative Health (NCCIH) National Institute of Neurological Disorders and Stroke (NINDS)